You are here

  • Home
  • Archive
  • Volume 3, Issue 11
  • Factors influencing clinical trial site selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study)

Responses

Article menu
XML
Health policy
Research
Factors influencing clinical trial site selection in Europe: the Survey of Attitudes towards Trial sites in Europe (the SAT-EU Study)
Compose a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on: 23 November 2015
    Re:Leem Surveys on Attractiveness of France for International Clinical Trials

    Dear Dr Silbenair,

    Thank you very much for your interest in our paper, and for the interesting comments. I'd appreciate learning more about the situation of clinical trials in France. Please, email your reply to me at giuseppe.ambrosio@ospedale.perugia.it

    Thank you

    Conflict of Interest:

    None declared

    Conflict of Interest:
    None declared.
  • Published on: 23 November 2015
    Leem Surveys on Attractiveness of France for International Clinical Trials

    Thank you for this work which is very helpful for clinical trials site selection. We would like to inform about a work done in France on Clinical Research Attractiveness since 2002, and published early 2013 in Therapie Journal (Therapie 2013 Janvier-Fevrier;68 (1):1-18). A new Survey is on-going and the results will be available at the end of 2014 and then published. The abstract of the last publication is: Since 2002, th...

    Show More
    Conflict of Interest:
    None declared.